首页> 美国卫生研究院文献>Biomedicines >A Classic Herbal Formula Guizhi Fuling Wan for Menopausal Hot Flushes: From Experimental Findings to Clinical Applications
【2h】

A Classic Herbal Formula Guizhi Fuling Wan for Menopausal Hot Flushes: From Experimental Findings to Clinical Applications

机译:绝经期潮热的经典中药配方桂枝Fu丸:从实验结果到临床应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A classic herbal formula Guizhi Fuling Wan (GFW) has been used for managing menopausal hot flushes (MHFs), but the evidence across different study types has not been systematically summarized. This project investigated the clinical effects, phytochemistry, pharmacodynamics, and potential mechanisms of actions of GFW on the causative target proteins potentially driving MHFs. Twenty English and Chinese databases were searched for relevant clinical and experimental studies. A total of 12,988 studies were identified, of which 46 were included. Seven clinical studies demonstrated GFW had no statistically significant changes in the frequency and severity of MHFs; however, it could improve peripheral blood flow in the fingertips, jaw, and toes. Thirty-five studies on phytochemistry identified 169 chemical compounds of GFW. Four experimental studies revealed GFW’s therapeutic effects (e.g., normalize calcitonin gene-related peptide (CGRP) level) and potential target protein/cytokine (estrogen receptor beta (ESR2) with genetic variation, CGRP receptor, and interleukin-8) on MHFs. Therapeutic effects across different study types were inconsistent, possibly due to the dose difference and genotype variety of ESR2 in the human population. Further clinical and experimental studies, as well as biochemical investigation on the mechanisms of actions of GFW, are recommended.
机译:经典的草药配方桂枝Fu灵丸(GFW)已用于治疗更年期潮热(MHF),但尚未系统总结各种研究类型的证据。该项目研究了GFW对可能驱动MHF的致病靶蛋白作用的临床效应,植物化学,药效学和潜在作用机制。搜索了二十个英语和中文数据库,以进行相关的临床和实验研究。总共确定了12,988个研究,其中包括46个。七项临床研究表明,GFW在MHF的频率和严重程度方面没有统计学上的显着变化。但是,它可以改善指尖,下颌和脚趾的外周血流。 35项植物化学研究确定了169种GFW化合物。四个实验研究显示GFW对MHF的治疗作用(例如,使降钙素基因相关肽(CGRP)正常化)和潜在的靶蛋白/细胞因子(具有遗传变异的雌激素受体β(ESR2),CGRP受体和白介素8)。不同研究类型之间的治疗效果不一致,可能是由于人类人群中ESR2的剂量差异和基因型多样性所致。建议进一步的临床和实验研究,以及有关GFW作用机理的生化研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号